공지사항

Pancreatic Cancer Lawsuit Settlements

The diagnosis of pancreatic cancer early is difficult due to its aggressive nature. The prognosis of pancreatic cancer is contingent on the stage of the cancer, whether it can be surgically removed, and what other treatment options are available.

If you or someone you know developed pancreatic cancer kidney damage or a different serious illness after taking Prilosec or Nexium You may be eligible to file a PPI lawsuit. Find out more about submitting an action.

Januvia and Janumet Lawsuits

The Januvia pancreatic cancer lawsuits assert that Merck placed profits over consumer safety when it came to marketing the diabetes drug. Januvia is one of Merck's top-selling drugs, taking in more than $5.3 billion in sales since its launch.

A variety of post-marketing and academic studies indicate that there may be an relationship between incretin mimetics, such as Januvia (sitagliptin) and Pancreatic cancer lawsuit settlement cancer. This is of great issue as Pancreatic cancer railroad cancer settlements cancer often in advanced stages when it is first diagnosed, and there are a limited number of effective treatments.

Families of people who have died from pancreatic carcinoma have filed lawsuits against Merck, Amylin Pharmaceuticals Eli Lilly, and Bristol-Myers Squibb. The lawsuits claim that the defendants knew or should have been aware that their Type 2 Diabetes medications could cause pancreatic cancer, but failed to adequately inform patients and doctors of this risk.

In 2016 the court decided to combine the Januvia, Byetta and Pancreatic cancer lawsuit settlement Janumet lawsuits into a multidistrict lawsuit before Judge Anthony Battaglia in California. In 2017, the plaintiffs won an important victory when the 9th Circuit Court of Appeals upheld a lower court's decision which had dismissed and reinstituted the lawsuits.

People who took Januvia and have been diagnosed with Pancreatic cancer injuries cancer may be entitled to compensation for medical bills loss of earnings, funeral costs as well as pre-death pain and damages, and other losses. National Injury Help is reviewing potential lawsuits and offering a free consultations to those who are eligible.

Zantac Lawsuits

Zantac lawsuits began filing shortly after the FDA recalled the heartburn medication's over-the-counter version in 2022 due to the discovery of cancer-causing N-nitrosodimethylamine (NDMA) contamination. Over 50,000 claims were brought in federal courts after the discovery. The cases were consolidated into a single multidistrict case before U.S. District Judge Robin Rosenberg in Florida. Plaintiffs claimed Zantac's makers were aware of the dangers that ranitidine poses, but failed to inform customers. The lawsuits claim the companies were aware or ought to have known that the prescription medication was contaminated with NDMA and can cause bladder, esophageal, gastrointestinal, liver and Pancreatic cancer injury settlement cancer. Other claims claim that the over-the-counter medication caused other side effects, including diarrhea and ulcers.

The first trial in California was scheduled to begin this summer. A number of trials in the MDL would follow. However the MDL judge ruled against the case in December 2022 following a ruling that plaintiffs' expert evidence wasn't reliable. The judge claimed that the evidence of science was speculative and unconclusive to back the claims.

The decision is a huge blow to the hopes of plaintiffs who seek justice and fair compensation. We still hope that the bellwether trial scheduled for next week will give us a glimpse of the verdicts that juries could be handed out in these cases. If the trials prove successful they could help defendants settle claims more quickly.

Camp Lejeune Lawsuits

The Camp Lejeune Marine Corps Base was affected by volatile organic compounds found in the water it drank. The contamination resulted in serious health problems for those who lived or worked at the Marine base. Cancers like bladder cancer, kidney carcinoma multiple myeloma and non-Hodgkin lymphoma are among the diseases. If you or someone else in your family suffered injuries due to the polluted water at Camp Lejeune, our law firm can assist. Our personal injury, mass tort and product liability attorneys have a combined 130 years of experience. We have secured more than $250 million for our clients.

Anyone who lived or worked at Camp Lejeune 30 days or longer during the period of contamination is able to file a compensation claim. Anyone who has a family member who passed away from an illness believed to be linked to the contaminated drinking water at Camp Lejeune can also file a lawsuit for wrongful death.

A victim's case value is determined by the nature of their illness and how much the injury has affected their quality of life. A kidney cancer case, for instance is likely to have a higher value for settlement than claims for bladder cancer. Claims for bladder cancer, however are more likely to be linked to the contaminated Camp Lejeune water.

The Camp Lejeune lawsuits were consolidated into a multidistrict litigation (MDL) in the Eastern District of North Carolina federal court. The MDL will create a single complaint for all lawsuits and establish procedures to consolidate discovery, coordinate expert-related motions and dispositive motions, bellwether selection, trials and settlement negotiations.

Ranitidine Lawsuits

Millions of people across the United States take Zantac (and generic ranitidine) to treat acid reflux, ulcers and other stomach problems. Zantac was among the most popular medications ever until tests revealed that it may contain a potential cancer-causing chemical called NDMA.

Since the discovery of NDMA within ranitidine, thousands of lawsuits have been filed against the companies which manufacture and sell this popular medicine. These lawsuits were put together in a federal multidistrict lawsuit which is overseen by U.S. District judge Robin Rosenberg in Southern District of Florida. In addition to the MDL hundreds of lawsuits were filed in state courts.

The lawsuits assert that the makers of ranitidine knew about NDMA but did not warn consumers about the dangers. If the lawsuit is successful, plaintiffs could be awarded compensation for their injuries.

The defendants may try to keep certain claims out of court by saying that the evidence doesn't meet certain legal requirements. They will argue, in particular, that there isn't enough evidence to prove that NDMA found in Zantac could cause certain kinds of cancer. They could also argue that preexisting health conditions such as stomach polyps and obesity are the reason for the plaintiff's cancer rather than the NDMA in Zantac. If the plaintiff can prove that cancer was caused by the NDMA discovered in Zantac they could be able obtain damages.